News
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...
Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...
A newly discovered brain protein linked to Parkinson’s offers hope for targeted therapies that could slow or prevent disease ...
12don MSN
Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of ...
The disease, which is caused by mutations in the SOD1 gene, accounts for approximately 10% to 20% of genetic ALS cases and 1% to 2% of sporadic ALS cases, according to the ALS Association. 7.
Now, scientists at the University of Sydney have made an exciting discovery: they’ve found a new brain protein linked to ...
The U.S. Food and Drug Administration approved a new drug Tuesday to treat a rare form of amyotrophic lateral sclerosis, or ALS.. The drug Qalsody (tofersen) is expected to help people with a very ...
The decision on the SOD1 ALS program does not impact Voyager’s other gene therapy programs; the Company continues to expect IND filings in 2025 from Neurocrine Biosciences for the program in ...
4d
WarwickshireWorld on MSNPowerful life-sized ice sculpture of terminally-ill Rugby woman will demonstrate impact of motor neurone diseaseA life-sized ice sculpture of a terminally-ill Rugby woman will melt in the summer heat to demonstrate the devastating impact of Motor Neurone Disease.
LEXINGTON, Mass., Dec. 06, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today ...
DM is caused by inherited changes to a gene called superoxide dismutase 1, or SOD1. This gene gives instructions to the superoxide dismutase enzymes, which act as antioxidants and help rid the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results